A doctor discusses prostate cancer, testing, survival and Biden’s diagnosis
Dr. Leonard Marks, UCLA Health urology professor discusses former President Biden's prostate cancer diagnosis.
Cofounder, Avenda Health
Search every verified Leonard Marks interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a November 2022 presentation to the Prostate Forum of Orange County, Leonard Marks, a UCLA urology professor and cofounder of Avenda Health, discussed what he described as a dramatic transformation in prostate cancer management. Marks stated that MRI-guided biopsy has "changed everything" and argued that biopsies for suspected prostate cancer should be preceded by an MRI, saying, "if you get the biopsy wrong the whole journey will be badly affected." He noted that his team was among the first in the United States to use the FDA-approved Artemis image-fusion device for targeted biopsies. Marks also discussed focal therapy options for localized prostate cancer, including cryotherapy, high-intensity focused ultrasound (HIFU), and focal laser ablation, which he said his startup is working to commercialize for use in a clinic rather than an operating room. He estimated that up to 40 percent of newly diagnosed prostate cancer cases may be candidates for focal therapy. Marks additionally highlighted the PSMA scan (Pylarify) as the most sensitive method for detecting metastases and noted that the PIRADS scoring system is used internationally, with PIRADS five lesions harboring clinically significant cancer about 80 percent of the time.
Dr. Leonard Marks, UCLA Health urology professor discusses former President Biden's prostate cancer diagnosis.
Active Surveillance Patients International (ASPI) welcomes Dr. Leonard Marks, Professor of Urology at UCLA, alongside Meghan Tierney, PhD, RN, and Mia Li-Burton from Artera AI, to explore how Active Surveillance continues to evolve through imaging, focal therapy, and artificial intelligence. Dr. Marks shares insights from UCLA’s 5,000-patient database and explains how mapping prostate lesions with MRI and AI can help predict who will remain stable on surveillance. The team from Artera AI discusses the science behind their new Artera AI Prostate Test, now included in the NCCN Guidelines, which…
"This is not Your Father's Prostate Cancer." Dr. Marks talks about the revolutionary advances in detection of prostate cancer, and the target biopsy program at UCLA and elsewhere. Prostate Forum of Orange County is a Southern California Prostate Cancer Support Group, with online (Zoom) meetings on the second and fourth Tuesday of most months, beginning at 5:00 p. Pacific Time. Our website address is: www.prostateforum.org
Dr. Leonard Marks lectures on contemporary management of Prostate Cancer.
Channel 11 Highlights UCLA Active Surveillance Program Dr. Leonard Marks, a clinical professor of urology, was featured Sept. 2 in a Fox 11 News story on UCLA's active surveillance program that forgoes surgical treatment for prostate cancer patients in favor of close monitoring and periodic biopsies. Learn more about Active Surveillance & Watchful Waiting: http://urology.ucla.edu/body.cfm?id=246 Video courtesy FOX News
Sign in to search the full transcript archive, filter by topic, and access every quote from Leonard Marks.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans